Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Newly Diagnosed Carcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT00616967
What this trial is testing

Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer

Who this might be right for
Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 68
Very early researchEnded earlyNCT03361800
What this trial is testing

Window of Opportunity Trial of Entinostat in Patients With Newly Diagnosed Stage I-IIIC,TNBC

Who this might be right for
Breast CancerInvasive Breast CancerER-Negative PR-Negative HER2-Negative Breast Cancer
UNC Lineberger Comprehensive Cancer Center 5
Large-scale testing (Phase 3)Study completedNCT01104584
What this trial is testing

Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast Magnetic Resonance Imaging (MRI)

Who this might be right for
Breast Cancer
Bayer 460
Testing effectiveness (Phase 2)UnknownNCT01830244
What this trial is testing

IST Neoadjuvant Abraxane in Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Barwon Health 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02238808
What this trial is testing

See Whether Estrogen Can Slow the Growth of Some ER Positive Breast Cancers

Who this might be right for
Estrogen Receptor Positive Breast Cancer
AHS Cancer Control Alberta 19
Not applicableStudy completedNCT00569543
What this trial is testing

Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
University of Nebraska 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT06048718
What this trial is testing

T-DXd Therapy for HER2-low Breast Cancer Patients With Brain Metastases

Who this might be right for
Breast CancerMetastatic Breast Cancer
MedSIR 28
Testing effectiveness (Phase 2)WithdrawnNCT06829199
What this trial is testing

A Clinical Study of Boserolimab (MK-5890) With Pembrolizumab and Chemotherapy in People With Early Triple-Negative Breast Cancer (MK-5890-003)

Who this might be right for
Early Triple Negative Breast Cancer
Merck Sharp & Dohme LLC
Not applicableStudy completedNCT01892540
What this trial is testing

PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer

Who this might be right for
Breast CancerUnspecified Adult Solid Tumor, Protocol Specific
Case Comprehensive Cancer Center 43
Not applicableWithdrawnNCT01159236
What this trial is testing

Molecular Triaging of Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00482755
What this trial is testing

Sunitinib in Treating Patients With Newly Diagnosed Stage II or Stage III Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 4
Not applicableUnknownNCT00463034
What this trial is testing

Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
University of Sheffield 1,800
Not applicableStudy completedNCT03027063
What this trial is testing

Impact of Exercise on Mitigating the Cardio-toxic Effects of Adriamycin Among Women Newly Diagnosed With Breast Cancer.

Who this might be right for
Breast Cancer FemaleAdriamycin Toxicity
Johns Hopkins University 21
Very early researchLooking for participantsNCT05659797
What this trial is testing

FES BPET-DBT in Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Abramson Cancer Center at Penn Medicine 20
Testing effectiveness (Phase 2)Ended earlyNCT01230970
What this trial is testing

Exploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Ipsen 2
Not applicableStudy completedNCT00783822
What this trial is testing

Effects of Rapid Genetic Counseling and Testing in Newly Diagnosed Breast Cancer Patients

Who this might be right for
Breast Neoplasms
The Netherlands Cancer Institute 265
Early research (Phase 1)WithdrawnNCT04142554
What this trial is testing

Parsaclisib in Newly Diagnosed Stage I-IIIC Triple Negative or HER2+ Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmsTriple Negative Breast Cancer+1 more
UNC Lineberger Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00010023
What this trial is testing

Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Cancer
NYU Langone Health
Not applicableStudy completedNCT01386411
What this trial is testing

Understanding Decision Making Processes for Undergoing Genetic Testing Among Women With Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 108
Testing effectiveness (Phase 2)Ended earlyNCT04191382
What this trial is testing

Phase 2 Window Study of SAR439859 (Amcenestrant) Versus Letrozole in Post-menopausal Patients With ER+, HER2- Pre-operative Post-menopausal Primary Breast Cancer

Who this might be right for
Breast Cancer
Sanofi 105
Next Page